학술논문

Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children
Document Type
Article
Source
In: International Journal of Infectious Diseases. (International Journal of Infectious Diseases, January 2023, 126:164-173)
Subject
Language
English
ISSN
18783511
12019712